Skip to main content

Table 5 Associations between candidate correlating factors and percent change in CA125 levels among postmenopausal women (N = 1116) by univariable and multivariable linear regressions

From: Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study

Variables

Univariable linear regressionsa

Multivariable linear regressionsb

 

Effect estimate

CA125 change

P value

Effect estimate

Standard error

CA125 change

P value

Smoking

 Current

−0.096

−9.15%

0.258

    

 Former

−0.014

−1.39%

0.835

    

 None

ref

      

EtOH

  > 2 drinks/day

−0.178

−16.31%

0.076

−0.267

0.129

−23.43%

0.055

 1–2 drinks/day

0.021

2.12%

0.545

0.050

0.072

5.13%

0.499

 None

ref

      

Caffeine

−0.0002

−0.02%

0.034

−0.00002

0.0002

−0.002%

0.887

Age of menarche

  > 12

0.020

2.02%

0.687

    

  ≤ 12

ref

      

Breastfeedc

0.020

2.02%

0.689

    

OCP duration

 10+ years

0.009

0.90%

0.914

    

 5–10 years

−0.002

−0.20%

0.978

    

 2–5 years

0.070

7.25%

0.543

    

  < 2 years

ref

      

CRP

0.057

5.87%

0.074

−0.028

0.069

−2.76%

0.696

Ferritin

−0.0003

−0.03%

0.138

0.00062

0.0006

0.06%

0.473

Osteoporosis

−0.017

−1.69%

0.750

    

Osteoarthritis

−0.048

−4.69%

0.333

    

Hysterectomy

−0.084

−8.06%

0.050

−0.095

0.120

−9.06%

0.441

Oophorectomy

−0.104

−9.88%

0.061

−0.050

0.102

−4.88%

0.628

Salpingectomy

0.044

4.50%

0.381

    

Endometriosis

−0.205

−18.54%

0.126

−0.068

0.112

−6.57%

0.554

Fibroids

−0.242

−21.49%

0.046

−0.161

0.132

−14.87%

0.242

CADd

0.131

14.00%

0.134

0.249

0.115

28.27%

0.047

HLD

0.054

5.55%

0.364

    

Non-ovarian cancer

−0.048

−4.69%

0.299

    
  1. EtOH alcohol, CHC current hormonal contraception, OCP oral contraceptive pill, CRP C reactive protein, CAD coronary artery disease, HLD hyperlipidemia
  2. a All univariable regressions were adjusted for baseline variables including age, race/ethnicity, BMI, parity and current hormonal replacement therapy (HRT) use
  3. b Multivariable regressions included the baseline variables (age, race/ethnicity, BMI, parity, HRT) and eligible variables from univariable analyses with cut-off p value < 0.25
  4. c For the “Breastfeed” variable, the reference for parity is one instead of none
  5. d This variable demonstrated significant association with CA125 level in the multivariable linear regression model